News

Biohellenika, the provider of cord blood stem cell banking services in Greece, will be the exclusive provider of the StemSource Cell Bank cryopreservation services in Greece. The StemSource

Biolex is applying its proprietary glycosylation optimization technology to the antibody, BLX-301, to enhance efficacy and potency of the product candidate and potentially reduce certain side effects. Biolex

The contract is valued at approximately $32.3 million over a seven-year period. DynPort Vaccine (DVC) is teaming with Quintiles Transnational to complete this work. Under the terms of

Ms Russell served as partner, director, and senior manager at Insero & Company CPA’s, since 2001. As a partner in the outsource accounting services group, she dealt with

Under the terms of the agreement, Nycomed will be responsible for all costs associated with current and future clinical development, manufacturing and commercialization of veltuzumab in subcutaneous formulation

This designation was granted based on the recommendation of the European Medicines Evaluation Agency (EMEA) following a positive opinion from the Committee for Orphan Medicinal Products. Orphan designation

The Phase III clinical trials in the US and China on which this approval was based demonstrated that Abraxane doubled the response rate, significantly prolonged time to tumor

Under the terms of the agreement, Biologics Delivery Systems will supply catheters for the upcoming Phase I/II clinical trial of Gamida Cell’s CardioCure product for the treatment of

According to TheraGenetics, the strategic expansion into the area of depression underscores the company’s commitment to licensing new technologies to build a foundation for future diagnostic tests for